Re: Resverlogix Announces Eighth Positive Data Safety Monitoring Board Recommendation For Phase 3 Study of Apabetalone
|
1
|
Resverlogix Corp.
|
Dec 19, 2018 09:01AM
|
Re: Is this important,..
|
1
|
Resverlogix Corp.
|
Dec 19, 2018 05:23PM
|
Re: C'mon Don, fill up the dang car.....
|
2
|
Resverlogix Corp.
|
Dec 20, 2018 12:17AM
|
Re: Third Eye and Topline
|
1
|
Resverlogix Corp.
|
Dec 20, 2018 06:36AM
|
Re: Third Eye and Topline
|
1
|
Resverlogix Corp.
|
Dec 20, 2018 09:49AM
|
Re: Coronary Artery Calcium Score
|
4
|
Resverlogix Corp.
|
Dec 21, 2018 11:25AM
|
Re: Holding steady
|
4
|
Resverlogix Corp.
|
Dec 21, 2018 05:38PM
|
Re: Holding steady
|
3
|
Resverlogix Corp.
|
Dec 21, 2018 10:26PM
|
Re: Holding steady
|
5
|
Resverlogix Corp.
|
Dec 22, 2018 10:42AM
|
Re: Holding steady
|
2
|
Resverlogix Corp.
|
Dec 22, 2018 11:01AM
|
Re: Holding steady
|
5
|
Resverlogix Corp.
|
Dec 22, 2018 03:23PM
|
Re: We held up well again today,..
|
3
|
Resverlogix Corp.
|
Dec 26, 2018 03:53PM
|
Potential Buyers Have a Lot of Cash
|
3
|
Resverlogix Corp.
|
Dec 26, 2018 04:26PM
|
Re: Adjudication
|
2
|
Resverlogix Corp.
|
Dec 28, 2018 02:07PM
|
Re: NASH is a $35 Billion US/year market
|
3
|
Resverlogix Corp.
|
Dec 31, 2018 12:56PM
|
Re: A busy last half hour of trading to close out 2018
|
3
|
Resverlogix Corp.
|
Dec 31, 2018 09:25PM
|
Share Price
|
2
|
Resverlogix Corp.
|
Jan 04, 2019 10:48AM
|
Re: rndbtl on IV - Sanofi's relationship with Rothschild
|
4
|
Resverlogix Corp.
|
Jan 14, 2019 07:43PM
|
250 MACE scenario question
|
1
|
Resverlogix Corp.
|
Jan 23, 2019 05:12PM
|
Re: Contest Tally
|
1
|
Resverlogix Corp.
|
Feb 17, 2019 12:14AM
|